BANC vs SFNC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BANC exhibits mixed financial health with a weak Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full distress risk assessment. While earnings growth is strong (56.8% YoY) and profitability margins are high, low ROE (5.99%) and ROA (0.62%) suggest inefficient asset utilization. The stock trades below the analyst target of $23.14 but above the conservative Graham Number of $21.94, implying modest upside with moderate risk. Insider selling and a bearish technical trend temper otherwise positive growth and valuation signals.
The deterministic health baseline is critical, with a Piotroski F-Score of 1/9 indicating severe financial deterioration. Despite a recent price rally and strong YoY earnings growth, the company is reporting negative ROE (-10.37%) and ROA (-1.40%), suggesting fundamental instability. The stock trades at a discount to book value (P/B 0.91), which is a typical market reaction to the poor health metrics. The disconnect between the bullish analyst consensus and the failing deterministic scores suggests a high-risk profile.
Compare Another Pair
Related Comparisons
BANC vs SFNC: Head-to-Head Comparison
This page compares Banc of California, Inc. (BANC) and Simmons First National Corporation (SFNC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.